<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> (FA) have an extraordinary predisposition to <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The genetic mechanisms underlying the <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> of FA hematopoietic cells are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we have investigated the molecular features of hematopoiesis in the course of FA at different stages of the disease, including <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The analysis focused on defining the clonality status of FA hematopoiesis as well as the putative involvement of N-ras, a dominantly acting oncogene, and p53, a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene, which are known to play a role in human <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Clonality of hematopoiesis was assessed by testing X-chromosome inactivation at the DXS255 locus, which displays different methylation patterns according to the activation status of the corresponding X homolog </plain></SENT>
<SENT sid="5" pm="."><plain>Five out of seven FA cases analysed for clonality displayed monoclonal hematopoiesis, including one case at the <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> stage, three cases with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and one with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Mutations of the N-ras and p53 genes were studied by a combination of single strand conformation polymorphism (SSCP) analysis and direct sequencing of the PCR product in the bone marrow and/or peripheral blood of 18 FA patients (seven with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, seven with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, four with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>Only <z:mpath ids='MPATH_458'>normal</z:mpath> N-ras and p53 sequences were detected in <z:hpo ids='HP_0000001'>all</z:hpo> cases analyzed </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that monoclonal hematopoiesis is a frequent finding in the course of FA and may precede the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> in some cases </plain></SENT>
<SENT sid="9" pm="."><plain>The genetic mechanisms underlying FA-associated <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> appear to be independent of N-ras and p53 mutations, which are relatively frequent events in <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid tumors</z:e> associated with other <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> </plain></SENT>
</text></document>